Retrophin, Inc. (RTRX): Hedge Funds Are Crazy About This Fallen Angel

Page 14 of 14

Page 14 of 14 – SEC Filing
Exhibit A
AGREEMENT
The
undersigned agree that this Schedule 13G dated March 31, 2016 relating to the Common Stock, par value $0.0001 per share of
Retrophin, Inc. shall be filed on behalf of the undersigned.
SCOPIA CAPITAL MANAGEMENT LP
By: /s/ Samantha Nasello
Name:  Samantha Nasello
Title:  CCO
SCOPIA MANAGEMENT, INC.
By: /s/ Aaron Morse
Name:  Aaron Morse
Title:  Vice President
By: /s/ Matthew Sirovich
Name:  Matthew Sirovich
By: /s/ Jeremy Mindich
Name:  Jeremy Mindich
SCOPIA WINDMILL
FUND LP
By: /s/ Aaron Morse
Name:  Aaron Morse
Title:  COO
SCOPIA CAPITAL GP LLC
By: /s/ Aaron Morse
Name:  Aaron Morse
Title:  Vice President

Follow Travere Therapeutics Inc. (NASDAQ:TVTX)

Page 14 of 14